Does RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS Cause Dyspnoea? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Dyspnoea have been filed in association with RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS. This represents 25.0% of all adverse event reports for RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS.
5
Reports of Dyspnoea with RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS
25.0%
of all RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS reports
5
Deaths
5
Hospitalizations
How Dangerous Is Dyspnoea From RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS?
Of the 5 reports, 5 (100.0%) resulted in death, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOFLAVIN 5^-PHOSPHATE ANHYDROUS Cause?
Off label use (6)
Drug hypersensitivity (5)
Incorrect route of product administration (5)
Sleep disorder (5)
Swelling (5)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)